Compass Pathways Plc (CMPS NASDAQ) stock market data APIs
$10.635
0.91(8.6%)
as of May 18, 2026
Try our APIs with
free plan!
Compass Pathways Plc Financial Data Overview
Price chart is built with
Anychart
COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. The company develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. The company was incorporated in 2020 and is headquartered in London, the United Kingdom.
Prev. Close
10.635
Open
11.5448
High
11.59
Low
10.3888
52 wk Range
2.25-11.65
Market Cap
1 432 M
Shares Outstanding
135 M
EPS
-0.305
Beta
2.405
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Compass Pathways Plc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Compass Pathways Plc data using free add-ons & libraries
Get Compass Pathways Plc Fundamental Data
Compass Pathways Plc Fundamental data includes:
- Net Revenue:
- EBITDA: -175 074 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-05-07
- EPS/Forecast: -0.4504
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Compass Pathways Plc News
New
This Psychedelics Stock Just Keeps Getting Hotter; Why Shares Bypassed A Profit-Taking Zone
Compass Pathways surged Monday on growing enthusiasm for the company's psilocybin-based approach to treatment-resistant depression. Continue Reading
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
Key Takeaways; Cannabis Sector Organigram Reported its Second Quarter Fiscal 2026 Financial Results Village Farms Reported Q1 2026 Results Driven by Record International Export Sales Cronos Group Rep...
At a glance: stocks gapping up premarket
[Wall Street New York City] aluxum/E+ via Getty Images Here's a quick look at the stocks that are seeing gap-up moves before the bell Monday. Stock index futures (SPX [https://seekingalpha.com/symbo...
Compass Pathways to Participate in RBC Capital Markets Global Healthcare Conference on May 19-20, 2026
LONDON & NEW YORK, May 14, 2026--(BUSINESS WIRE)--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, a...
Get Compass Pathways Plc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
